163 related articles for article (PubMed ID: 12748385)
1. An EP2 receptor-selective prostaglandin E2 agonist induces bone healing.
Paralkar VM; Borovecki F; Ke HZ; Cameron KO; Lefker B; Grasser WA; Owen TA; Li M; DaSilva-Jardine P; Zhou M; Dunn RL; Dumont F; Korsmeyer R; Krasney P; Brown TA; Plowchalk D; Vukicevic S; Thompson DD
Proc Natl Acad Sci U S A; 2003 May; 100(11):6736-40. PubMed ID: 12748385
[TBL] [Abstract][Full Text] [Related]
2. A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing.
Li M; Ke HZ; Qi H; Healy DR; Li Y; Crawford DT; Paralkar VM; Owen TA; Cameron KO; Lefker BA; Brown TA; Thompson DD
J Bone Miner Res; 2003 Nov; 18(11):2033-42. PubMed ID: 14606517
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: In vivo and in vitro evidence.
Graham S; Gamie Z; Polyzois I; Narvani AA; Tzafetta K; Tsiridis E; Helioti M; Mantalaris A; Tsiridis E
Expert Opin Investig Drugs; 2009 Jun; 18(6):746-66. PubMed ID: 19426119
[TBL] [Abstract][Full Text] [Related]
4. Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation.
Cameron KO; Lefker BA; Ke HZ; Li M; Zawistoski MP; Tjoa CM; Wright AS; DeNinno SL; Paralkar VM; Owen TA; Yu L; Thompson DD
Bioorg Med Chem Lett; 2009 Apr; 19(7):2075-8. PubMed ID: 19250823
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
Kay LJ; Yeo WW; Peachell PT
Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
[TBL] [Abstract][Full Text] [Related]
6. Role of EP2 receptors and cAMP in prostaglandin E2 regulated expression of type I collagen alpha1, lysyl oxidase, and cyclooxygenase-1 genes in human embryo lung fibroblasts.
Choung J; Taylor L; Thomas K; Zhou X; Kagan H; Yang X; Polgar P
J Cell Biochem; 1998 Nov; 71(2):254-63. PubMed ID: 9779823
[TBL] [Abstract][Full Text] [Related]
7. Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development.
Abran D; Dumont I; Hardy P; Peri K; Li DY; Molotchnikoff S; Varma DR; Chemtob S
Circ Res; 1997 Apr; 80(4):463-72. PubMed ID: 9118476
[TBL] [Abstract][Full Text] [Related]
8. E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2.
Okano M; Sugata Y; Fujiwara T; Matsumoto R; Nishibori M; Shimizu K; Maeda M; Kimura Y; Kariya S; Hattori H; Yokoyama M; Kino K; Nishizaki K
Immunology; 2006 Jul; 118(3):343-52. PubMed ID: 16827895
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
[TBL] [Abstract][Full Text] [Related]
10. Study on Physiological Roles of Stimulation of Prostaglandin E2 Receptor Subtype EP2 in Urethral Function in Rats.
Kurihara R; Ishizu K; Takamatsu H; Yoshino T; Masuda N
Low Urin Tract Symptoms; 2016 May; 8(2):125-9. PubMed ID: 27111625
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts.
Noguchi K; Iwasaki K; Shitashige M; Endo H; Kondo H; Ishikawa I
J Dent Res; 2000 Dec; 79(12):1955-61. PubMed ID: 11201045
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
[TBL] [Abstract][Full Text] [Related]
13. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs.
Suzawa T; Miyaura C; Inada M; Maruyama T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Suda T
Endocrinology; 2000 Apr; 141(4):1554-9. PubMed ID: 10746663
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E(2) receptors in bone formation.
Li M; Thompson DD; Paralkar VM
Int Orthop; 2007 Dec; 31(6):767-72. PubMed ID: 17593365
[TBL] [Abstract][Full Text] [Related]
15. Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4.
Xie C; Liang B; Xue M; Lin AS; Loiselle A; Schwarz EM; Guldberg RE; O'Keefe RJ; Zhang X
Am J Pathol; 2009 Aug; 175(2):772-85. PubMed ID: 19628768
[TBL] [Abstract][Full Text] [Related]
16. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor.
Zeng L; An S; Goetzl EJ
Biochemistry; 1996 Jun; 35(22):7159-64. PubMed ID: 8679543
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha.
Yan M; Noguchi K; Ruwanpura SM; Ishikawa I
J Periodontol; 2005 Jun; 76(6):929-35. PubMed ID: 15948687
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 receptor subtype EP-2 is not involved in the induction of non-pregnant guinea pig uterine contractions associated with terminal pregnancy.
Lebel W; Riccardi K; Grasser WA; Terry K; Thompson D; Paralkar VM
Prostaglandins Leukot Essent Fatty Acids; 2004 Dec; 71(6):399-404. PubMed ID: 15519499
[TBL] [Abstract][Full Text] [Related]
19. Lack of interaction between prostaglandin E2 receptor subtypes in regulating adenylyl cyclase activity in cultured rat dorsal root ganglion cells.
Wise H
Eur J Pharmacol; 2006 Mar; 535(1-3):69-77. PubMed ID: 16545798
[TBL] [Abstract][Full Text] [Related]
20. Role of EP2 and EP4 receptor-selective agonists of prostaglandin E(2) in acute and chronic kidney failure.
Vukicevic S; Simic P; Borovecki F; Grgurevic L; Rogic D; Orlic I; Grasser WA; Thompson DD; Paralkar VM
Kidney Int; 2006 Sep; 70(6):1099-106. PubMed ID: 16871242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
